Manufactures pharmaceuticals for human consumption in China.
Sep 2025Revenue $17.9B/yrExpenses $20.8B/yr
Fell below break-even May 2022
Figures by year
When will Universe Pharmaceuticals be profitable again?
Its expenses passed its revenue in May 2022. In the 12 months to Sep 2025, revenue was $17.9B and expenses $20.8B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Sep 2025 | $17.9B | $20.8B | −$2.92B |
| Sep 2024 | $23.0B | $31.0B | −$8.02B |
| Sep 2023 | $32.3B | $36.3B | −$3.97B |
| Sep 2022 | $40.1M | $47.2M | −$7.02M |
| Sep 2021 | $48.0M | $34.4M | $13.6M |
| Sep 2020 | $30.7M | $20.5M | $10.3M |
| Sep 2019 | $33.2M | $23.5M | $9.75M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.